NewsJanuary 29, 2021AZ/Daiichi Sankyo’s partnership makes progress in lung cancer Share XAZ/Daiichi Sankyo’s partnership makes progress in lung cancerhttps://pharmaphorum.com/news/az-daiichi-sankyos-partnership-makes-progress-in-lung-cancer/
Views and analysisJanuary 22, 2021Assessing physician practices and expectations in the post-COVID era Share XAssessing physician practices and expectations in the post-COVID erahttps://pharmaphorum.com/views-analysis-patients/assessing-physician-practices-and-expectations-in-the-post-covid-era/
NewsJanuary 18, 2021AZ/Daiichi Sankyo’s Enhertu gets second US cancer indication Share XAZ/Daiichi Sankyo’s Enhertu gets second US cancer indicationhttps://pharmaphorum.com/news/az-daiichi-sankyos-enhertu-gets-second-us-cancer-indication/
NewsDecember 18, 2020MacroGenics’ HER2 breast cancer drug Margenza approved in US Share XMacroGenics’ HER2 breast cancer drug Margenza approved in UShttps://pharmaphorum.com/news/macrogenics-her2-breast-cancer-drug-margenza-approved-in-us/
NewsDecember 14, 2020Daiichi Sankyo, AZ close on EU approval of Enhertu for breast cancer Share XDaiichi Sankyo, AZ close on EU approval of Enhertu for breast cancerhttps://pharmaphorum.com/news/daiichi-sankyo-az-close-on-eu-approval-of-enhertu-for-breast-cancer/
NewsJuly 27, 2020AstraZeneca inks $6bn cancer drug deal with Daiichi Sankyo Share XAstraZeneca inks $6bn cancer drug deal with Daiichi Sankyohttps://pharmaphorum.com/news/astrazeneca-inks-6bn-cancer-drug-deal-with-daiichi-sankyo/
NewsJune 21, 2020After Celgene deal, BMS shoots up pharma market cap rankings Share XAfter Celgene deal, BMS shoots up pharma market cap rankingshttps://pharmaphorum.com/news/after-celgene-deal-bms-shoots-up-pharma-market-cap-rankings/
NewsMay 30, 2020ASCO data back AZ/Daiichi Sankyo’s Enhertu in new HER2 cancers Share XASCO data back AZ/Daiichi Sankyo’s Enhertu in new HER2 cancershttps://pharmaphorum.com/news/asco-2020-astrazeneca-enhertu-cancer/
NewsMay 18, 2020AZ/Daiichi’s Enhertu gains second ‘breakthrough’ tag in space of a week Share XAZ/Daiichi’s Enhertu gains second ‘breakthrough’ tag in space of a weekhttps://pharmaphorum.com/news/azs-enhertu-gains-second-breakthrough-tag-in-space-of-a-week/
NewsMay 14, 2020AstraZeneca to unveil key data for cancer drugs at ASCO Share XAstraZeneca to unveil key data for cancer drugs at ASCOhttps://pharmaphorum.com/news/astrazeneca-to-unveil-key-data-for-cancer-drugs-at-asco/
NewsMay 11, 2020AZ/Merck & Co’s ovarian cancer drug gets wider US licence Share XAZ/Merck & Co’s ovarian cancer drug gets wider US licencehttps://pharmaphorum.com/news/az-merck-co-ovarian-cancer-drug-gets-wider-us-licence/
NewsFebruary 17, 2020Blockbusters in waiting: drug launches to watch in 2020 Share XBlockbusters in waiting: drug launches to watch in 2020https://pharmaphorum.com/news/blockbusters-in-waiting-drug-launches-to-watch-in-2020/
